anesthetic management of MITRAL stenosis pregnant women

Reading File

Finding Sources

Searching PubMed

"mitral stenosis" AND pregnancy AND anesthesia

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have comprehensive content from multiple authoritative textbooks. Let me compile the full, detailed answer.

Anesthetic Management of Mitral Stenosis in Pregnant Women

Pathophysiology: Why Mitral Stenosis is So Dangerous in Pregnancy

Mitral stenosis (MS) creates a fixed obstruction to left ventricular inflow. The left atrium must generate a higher-than-normal pressure gradient to push blood across the narrowed valve, and left atrial pressure (LAP) is directly governed by:

LAP = LVDP + [flow / (K × MVA)]²

Where MVA = mitral valve area, flow = cardiac output / diastolic filling time. Any factor that increases cardiac output or decreases diastolic filling time (i.e., tachycardia) raises LAP and risks pulmonary edema.

Pregnancy imposes all three hemodynamic stressors simultaneously:

Blood volume increases by 40-50%
Cardiac output rises 30-50%
Heart rate increases

These changes can raise the transmitral pressure gradient and cause pulmonary edema or tachyarrhythmias. About 50% of pregnant women with severe MS experience pulmonary edema during pregnancy. Maternal mortality risk is highest in the third trimester and puerperium. Severe MS with right-sided heart failure or pulmonary hypertension is WHO class IV - pregnancy is contraindicated.

Creasy & Resnik's Maternal-Fetal Medicine, p. 1259
Miller's Anesthesia, p. 8892
Barash Clinical Anesthesia, p. 3296

Risk Stratification and Preoperative Assessment

Modified WHO Classification

WHO III (significant risk): moderate MS, MVA 1.0-1.5 cm²
WHO IV (extremely high risk, pregnancy contraindicated): severe MS (MVA < 1.0 cm²), severe pulmonary hypertension

Multidisciplinary "Pregnancy Heart Team"

ACOG recommends an individualized delivery plan be determined between 20 and 30 weeks through shared decision-making among patient, obstetrician, anesthesiologist, cardiologist, and cardiac surgeon. Patients should ideally be managed at a tertiary care center.

Key Preoperative Questions

MVA (by echocardiography - 2D planimetry or Gorlin formula)
Degree of pulmonary hypertension (PAP on echo)
Presence/absence of atrial fibrillation (AF)
NYHA functional class
Anticoagulation status (heparin vs. LMWH, timing of last dose before neuraxial)
Previous valvuloplasty or valve surgery
Miller's Anesthesia, p. 8892

Hemodynamic Goals

The following table summarizes the goals (from Barash's Clinical Anesthesia, Table 39-3):

Parameter	Goal	Rationale
Heart Rate	Low normal (60-80 bpm)	Tachycardia shortens diastolic filling time, dramatically raises LAP
Rhythm	Sinus rhythm preferred	AF causes loss of atrial kick and rate acceleration
Preload	Maintain (avoid hypovolemia AND hypervolemia)	Preload dependent but fixed orifice; over-hydration causes pulmonary edema
Afterload (SVR)	Maintain or mildly elevated	Avoid sudden drops in SVR; use vasopressors if hypotension occurs
RV Afterload (PVR)	Minimize	Avoid hypoxia, hypercarbia, acidosis, hypothermia - all raise PVR
Contractility	Maintain/support RV	LV usually preserved; RV dysfunction from chronic pulmonary hypertension

Morgan & Mikhail's Clinical Anesthesiology, p. 703
Barash Clinical Anesthesia, p. 3296-3297

Mode of Delivery

Vaginal delivery is generally preferred for stable patients with compensated MS:

Less blood loss than cesarean
Avoids major abdominal surgery
Hemodynamically more stable overall
Epidural analgesia allows a controlled second stage (low-forceps/instrumental delivery to minimize Valsalva and cardiac stress)

Cesarean delivery is reserved for obstetric indications or severely decompensated patients where controlled delivery timing with a full cardiac team is needed.

Creasy & Resnik, p. 1259, p. 1316
Miller's Anesthesia, p. 8892-8893

Monitoring

Standard ASA monitors (SpO₂, ETCO₂, ECG with 5-lead if tachyarrhythmia risk)
Invasive arterial line - strongly recommended for moderate-to-severe MS; detects beat-to-beat BP changes and guides vasopressor titration
Central venous access (CVP monitoring) - helpful for fluid management
PA catheter - may be needed in severe MS with significant pulmonary hypertension; use with caution (PA rupture risk in long-standing PH)
TEE/TTE intraoperatively - excludes LA thrombus, monitors filling and function
Continuous ECG for arrhythmia detection
Miller's Anesthesia, p. 7621

Analgesia for Labor (Vaginal Delivery)

Epidural Analgesia - Preferred Technique

Epidural labor analgesia is strongly recommended for women with heart disease including MS. Benefits:

Decreases catecholamine release from pain
Eliminates the increase in cardiac output and tachycardia attributable to labor pain
Allows slow, titrated sympathectomy (avoids sudden preload/SVR changes)

Technique considerations:

Use a slow, incremental (titrated) epidural technique - avoid bolus loading doses
Dilute local anesthetic (e.g., bupivacaine 0.0625-0.1% + fentanyl 2 mcg/mL) allows good analgesia with minimal sympathectomy
Afterload reduction from epidural must be watched closely
Treat hypotension with a carefully titrated α-adrenergic agonist (phenylephrine preferred) to restore SVR without tachycardia (avoid ephedrine, which causes tachycardia)

Caution: Spinal anesthesia for labor is generally avoided due to rapid, uncontrolled sympathectomy. However, "saddle block" spinals (limited dermatomal spread) can be used carefully.

Miller's Anesthesia, p. 8892-8893
Morgan & Mikhail, p. 1806-1807 (neuraxial relative contraindication section)
Creasy & Resnik, p. 1730

Anesthesia for Cesarean Delivery

Neuraxial Anesthesia

Neuraxial anesthesia remains the preferred approach for most patients, but technique matters critically:

Technique	Applicability in MS	Key Concerns
Epidural (incremental)	Preferred for CS in moderate MS	Slow titration avoids sudden SVR drop; catheter allows top-ups
Combined Spinal-Epidural (CSE)	Acceptable if low-dose spinal used	Use low-dose spinal component + epidural titration to supplement
Spinal (single-shot)	Use with extreme caution in moderate-severe MS	Rapid, dense sympathectomy and SVR drop poorly tolerated; risk of cardiovascular collapse

Critical point: A high neuraxial block for cesarean delivery should be induced cautiously, if at all, in patients with:

Critical mitral stenosis
Severe pulmonary hypertension
Eisenmenger syndrome

If spinal is used despite this risk, pre-loading with careful fluid (not excessive), phenylephrine infusion prophylaxis, and having vasopressors drawn up are mandatory.

Creasy & Resnik, p. 1730-1731
Morgan & Mikhail, p. 1807

General Anesthesia

General anesthesia (GA) is considered when:

Neuraxial anesthesia is contraindicated (coagulopathy, anticoagulation, patient refusal)
Emergency cesarean with inadequate time for neuraxial
Hemodynamic instability precluding neuraxial
Severe decompensated MS requiring intubation anyway

GA induction considerations:

Avoid tachycardia at laryngoscopy - blunt the sympathetic response with:
- Fentanyl 2-3 mcg/kg pre-induction
- Lidocaine IV 1.5 mg/kg
- Esmolol 0.5-1 mg/kg (to control rate, but note fetal effects)
Etomidate for hemodynamically unstable patients (minimal cardiovascular depression)
Ketamine - relatively contraindicated due to tachycardia and SVR increase
Propofol/thiopental - use reduced doses; watch for hypotension and reflex tachycardia
Succinylcholine 1.5 mg/kg for rapid sequence intubation (standard for CS)
Maintain adequate depth to suppress tachycardia from surgical stimulation
Volatile agents - can be used for maintenance but dose-dependent vasodilation and myocardial depression; titrate carefully

Avoid intraoperatively:

Tachycardia from any cause (pain, light anesthesia, atropine, glycopyrrolate)
Hypoxia, hypercarbia, acidosis (all raise PVR and worsen RV function)
Excessive fluid loading (risk of pulmonary edema with fixed obstruction)

Management of Uterotonic and Tocolytic Agents

These obstetric drugs have hemodynamic effects that require careful selection in MS:

Drug	Effect	Use in MS
Oxytocin (slow infusion)	SVR decrease, tachycardia if bolus	Use slow infusion only (avoid bolus); bolus causes vasodilation and reflex tachycardia
Methylergonovine (Methergine)	Increases PVR and SVR	Avoid - worsens pulmonary hypertension
Carboprost (Hemabate, PGF2α)	Increases PVR	Avoid - worsens pulmonary hypertension
Misoprostol	Relatively safer; modest hemodynamic effects	Preferred uterotonic alternative
β-agonist tocolytics	Tachycardia	Contraindicated - tachycardia catastrophic in MS
Nifedipine (tocolysis)	SVR reduction	Use caution - may cause hypotension
Magnesium sulfate (bolus)	SVR reduction	Avoid bolus in MS

Creasy & Resnik, p. 1730

Management of Atrial Fibrillation

AF is particularly dangerous in MS because:

Loss of atrial kick reduces CO by an additional 20-30%
Rapid ventricular rate dramatically shortens diastolic filling time

Intraoperative new-onset AF:

Rate control first: IV metoprolol (1-5 mg IV increments), diltiazem, or digoxin
Target ventricular rate < 80 bpm
Synchronized cardioversion if hemodynamically unstable (monophasic 200 J or biphasic 120-200 J)
Anticoagulation to prevent LA thrombus (consider before cardioversion if duration > 48 hours)
Barash Clinical Anesthesia, p. 3296-3297
Creasy & Resnik, p. 1314

Balloon Mitral Valvuloplasty During Pregnancy

If the patient is unresponsive to aggressive medical therapy and has severe symptomatic MS with heart failure during pregnancy:

Percutaneous balloon mitral valvuloplasty (PBMV) is the treatment of choice
Safer for the fetus than open cardiac surgery (open surgery carries 20-30% fetal mortality vs. much lower for PBMV)
Lead shielding must be used to protect the fetus from fluoroscopic radiation
Best deferred until after the first trimester if possible
Anesthetic management for PBMV in pregnancy follows the same hemodynamic goals above
Creasy & Resnik, p. 1318-1320
Miller's Anesthesia, p. 8892

Special Considerations for Postpartum Period

The postpartum period carries the highest risk of decompensation because:

Autotransfusion from uterine contraction increases circulating blood volume by 300-500 mL rapidly
Aortocaval decompression also suddenly increases venous return
This volume surge is poorly tolerated by the fixed MS orifice, precipitating acute pulmonary edema

Postpartum management:

Continue invasive monitoring for 24-48 hours post-delivery
Have diuretics (furosemide) immediately available
Slow IV fluid replacement; avoid aggressive fluid resuscitation
Monitor for pulmonary edema, arrhythmias
Epidural catheter can remain in place for post-CS analgesia and allows gradual sympatholysis

Quick Summary: Anesthetic Priorities in MS in Pregnancy

Avoid tachycardia (target HR 60-80 bpm) - this is the single most critical goal
Use slow, incremental neuraxial techniques - epidural for labor and for CS
Treat SVR drops promptly with phenylephrine (not ephedrine)
Maintain preload but avoid fluid overload (narrow therapeutic window)
Avoid drugs causing tachycardia: ketamine, atropine, glycopyrrolate, oxytocin bolus, β-agonists
Avoid factors raising PVR: hypoxia, hypercarbia, acidosis, hypothermia, carboprost, methylergonovine
Multidisciplinary team delivery at a tertiary center
Vigilant postpartum monitoring for 24-48 hours (highest risk period)

Sources:

Miller's Anesthesia, 10th Ed., pp. 8892-8893 (Cardiac Disease in Pregnancy), pp. 7620-7622 (Anesthetic Management of MS)
Barash's Clinical Anesthesia, 9th Ed., pp. 3295-3297 (MS Hemodynamic Goals and Anesthetic Considerations)
Morgan & Mikhail's Clinical Anesthesiology, 7th Ed., pp. 703, 1806-1807
Creasy & Resnik's Maternal-Fetal Medicine, pp. 1257-1320, 1730-1731
Naik SA et al. "Anesthetic Management of Cesarean Sections in Parturients with Valvular Heart Disease." Ann Afr Med. 2025 [PMID: 40038558]
Cupido B et al. "Managing Rheumatic Heart Disease in Pregnancy." Can J Cardiol. 2021 [PMID: 34571164]

This is a shared conversation. Sign in to Orris to start your own chat.